GCF Levels of IL-1β and IL-6 in Gingivitis and Stage III-Grade C Periodontitis

Uşak University

Status: Completed

Conditions: Periodontitis

Treatments: Diagnostic Test: gingival crevicular fluid

Study type: Observational

Funder types: Other

Identifiers

NCT04689438

UsakU7

Details and patient eligibility

About

Periodontal diseases are chronic diseases that occur as a result of a violation of the balance between microbial dental plaque and the host response. Gingivitis is a disease characterized by inflammation of the gingiva that occurs in one or more areas without loss of attachments.1 in periodontitis, an inflammatory event that begins in the gingiva along with gingivitis spreads to the periodontal ligament, alveolar bone and soft tissues that support the tooth, causing the destruction of these structures.2 Cytokines are low molecular weight proteins that participate in the initial and active stages of inflammation and immunity. In periodontal disease pathogenesis, cytokine response has been reported to play a very critical role in determining disease progression.3 IL-1beta and IL-6 are key cytokines in chronic inflammatory diseases and have the potential to initiate bone loss and tissue destruction seen in periodontal disease.4the purpose of this study; it is to determine the degree of inflammation and periodontal destruction by determining the levels of IL-1beta and IL-6 cytokines in the gingival crevicular fluid of periodontal healthy and diseased individuals.

Full description

Periodontal measurement were done at 6 sites per tooth After clinical evaluation, individuals were divided into 3 groups

1. Healthy control groups:

   clinically healthy gingiva

2. Gingivitis groups:

   BOP score of 10% or greater and PD≤3mm

3. Periodontitis groups:

AL ≥5 mm, PD≥6 mm and tooth loss due to periodontitis of ≤4. GCF samples were collected using strips.

Enrollment: 64 patients

Sex: All

Ages: 20 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• have periodontitis
• have 16 permanent teeth

Exclusion criteria

• Systemic disease
• using drugs

Trial design

64 participants in 3 patient groups

Healthy control groups

Description:

clinically healthy gingiva BOP score less than 10%

Treatment:

Diagnostic Test: gingival crevicular fluid

Gingivitis groups

Description:

BOP score of 10% or greater

Treatment:

Diagnostic Test: gingival crevicular fluid

Periodontitis groups

Description:

interdental AL ≥5 mm, PD≥6 mm

Treatment:

Diagnostic Test: gingival crevicular fluid